Dr. Gerallt Williams, Director Scientific Affairs, Aptar Pharma

Dr. Gerallt WilliamsAfter obtaining his Ph.D. from the University of Wales, UK in 1985, Gerallt has held various industrial positions at Monsanto Inc. (UK), Fisons Ltd (UK), Valois (France) and Inhale/Nektar Therapeutics (USA).

Gerallt is now in charge of scientific affairs for the Aptar Pharma Prescription division, Le Vaudreuil, France and is engaged in the development of new devices for nasal, inhaled and injectable drug products.

What made you partner with Business Review Webinars?

Aptar Pharma wanted to reach out to a more global audience in order to share our enthusiasm about intra-nasal drug delivery which is a relatively new drug delivery approach and creating a webinar in partnership with BRW offered us the possibility to achieve this goal.

What do you enjoy the most about your role?

Developing new products that will hopefully bring some relief to patients suffering with difficult medical conditions is ultimately what we are trying to do day in and day out in our roles in the drug delivery industry – the enjoyment is in the journey.

What is your favourite place in the world and why?

I’m Welsh and I’ve been living in various countries during my career including Wales where I was born and grew up, England, the US and France. I feel well in France because I can enjoy a variety of unique experiences … while being so close to the UK!

What about nasal drug delivery are you most looking forward to sharing with the audience?

Although nasal drug delivery is somewhat of a niche area in the pharmaceutical industry we hope to share with the audience the future potential of this drug delivery approach, how ground-breaking and innovative research is being pursued with the possibility to open up a brand new way to treat some very serious and debilitating conditions which are predicted to become more prevalent over the coming decades.  Intranasal route is simple to access and non-invasive, it can be versatile (self-administration vs third-party’s-administration) and used for local and systemic/CNS nose-to-brain treatments – “The nose is the only natural corridor where the brain meets the outside world”.

What do you hope the audience will learn from this webinar?

The webinar is part educational, part setting the scene in the market place and part science and technology. Hopefully the audience will find some new information by participating in the webinar and may be able to identify opportunities for developing products for some of the unmet medical needs in this area via the nasal drug delivery approach.

Join Dr. Williams in the upcoming Aptar Pharma webinar: The Nasal Drug Delivery Journey: from Systemic to Nose-to-Brain? Register Now!

Leave a Reply

Your email address will not be published. Required fields are marked *